Nitrifying and denitrifying bacteria in aerobic granules formed in sequencing batch airlift reactors

Environmental fate and effects of granular pesta formulation from strains of Pseudomonas aeruginosa C1501 and Lasiodiplodia pseudotheobromae C1136 on soil activity and weeds

This work investigated the effect of variably formulated pesta granules containing wild and UV mutated Pseudomonas aeruginosa and Lasiodiplodia pseudotheobromae on the rate of CO2 evolution, organic carbon content, enzymatic activity (acidic and alkaline phosphatase, dehydrogenases, urease and protease) and representative soil microorganisms in the soils using different assay techniques. After the 35th day period of experiment, the pesta granule formulation BH4 showed the best evolution of CO2 (824 ± 6.2 mg CO2 kg-1 soil hr-1) as against control treatment (689 ± 3.7 mg CO2 kg-1 soil hr-1). Enzymes activities, organic carbon content of 3.8% on the 15th day of study and stable representation of microorganisms that include actinomycetes, fungi, heterogenous as well as soil nitrogen-mediatory bacteria were equally at their maximum level BH4 treatments. The phytotoxic assay showed no inhibitory effect on Solanum lycopersicum seeds and seedlings compared to the observed growth inhibition on the tested weeds (Amaranthus hybridus and Echinocholoa crus-galli) which corresponds with positive control glyphosate treatment. The glyphosate treated soil had the least critical results on parameters investigated during the study. The order of bioherbicidal activity is BH4>BH2>BH6>BH3>BH1>BH5>positive control. Results from this study confirmed the target efficacy of variably formulated pesta granules which is sustainable, cheap, ecologically suitable and recent. This is in addition to recognizing the microbial-derived formulations as characteristically potent alternative to chemical herbicides utility in agrosystems practice. Further study of the underlining factor responsible for the bioherbicidal performances of the variably formulated pesta granules and field trials are critical for their future commercialization.